end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccruedLiabilitiesCurrent,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,AvailableForSaleEquitySecuritiesGrossUnrealizedLoss,AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost,AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommitmentsAndContingencies,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractualObligation,ContractualObligationDueAfterFifthYear,ContractualObligationDueInFourthAndFifthYear,ContractualObligationDueInNextTwelveMonths,ContractualObligationDueInSecondAndThirdYear,ConversionGainsAndLossesOnForeignInvestments,ConversionOfStockAmountIssued1,ConversionOfStockSharesIssued1,DebtSecuritiesAvailableForSaleUnrealizedGainLoss,DeferredOfferingCosts,Depreciation,DepreciationAndAmortization,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectOfExchangeRateOnCashAndCashEquivalents,ForeignCurrencyTransactionGainLossUnrealized,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInOtherCurrentLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestIncomeExpenseNet,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear,MarketableSecuritiesCurrent,MarketableSecuritiesRealizedGainLoss,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,OperatingExpenses,OperatingIncomeLoss,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherNonoperatingExpense,OtherNonoperatingIncome,OtherNonoperatingIncomeExpense,OtherOperatingActivitiesCashFlowStatement,PaymentsToAcquireAvailableForSaleSecuritiesDebt,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerIncludingAssessedTax,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,StockholdersEquity,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityValueExcludingAdditionalPaidInCapital,UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation,WeightedAverageNumberOfSharesOutstandingBasic,AccruedEmployeeBenefitsCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,CommonStockCapitalSharesReservedForFutureIssuance,CurrentFederalTaxExpenseBenefit,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsInProcessResearchAndDevelopment,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsStateTaxes,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsUnrealizedCurrencyLosses,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesOtherFiniteLivedAssets,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationTaxCreditsOther,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,InterestIncomeExpenseNonoperatingNet,LeaseAndRentalExpense,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,NumberOfOperatingSegments,OtherAssets,PaymentsOfFinancingCosts,PropertyPlantAndEquipmentGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2020-12-31,2021-03-31,10-K,"Landos Biopharma, Inc.",LABP,CIK0001785345,USD,8606000.0,-213000.0,1939000.0,10000.0,1633000.0,833000.0,833000.0,21798696.0,30332000.0,29888000.0,25983000.0,,5640000.0,25718000.0,20078000.0,2416000.0,2416000.0,-7313000.0,0.0,0.01,200000000.0,40254890.0,12767909.0,71000.0,-30057000.0,,,,,,77000.0,,,87000.0,1398000.0,137000.0,,,-2.47,,0.0,0.0419,-79000.0,-79000.0,5338000.0,-30144000.0,6506000.0,161000.0,786000.0,532000.0,,,11310000.0,30332000.0,11034000.0,,25718000.0,,1518000.0,14131000.0,-22962000.0,-30144000.0,30676000.0,-30676000.0,87000.0,489000.0,276000.0,,,,,21718000.0,181000.0,0.01,10000000.0,0.0,0.0,356000.0,0.0,,36030000.0,1518000.0,-30144000.0,444000.0,25338000.0,-55729000.0,0.0,833000.0,,0.635,0.0032,,,400000.0,,,1225000.0,1249218.0,1.86,,,,,,,-54015000.0,-54015000.0,,,,,753000.0,73037000.0,100000.0,,12227823.0,,,53000.0,349000.0,22553065.0,,242000.0,856000.0,0.0,12294000.0,,27000.0,,81000.0,13341000.0,20000.0,0.21,-0.2553,0.0045,-0.0033,0.0023,-0.0001,,455000.0,200000.0,,,,,0.0,0.0,793000.0,0.0,,1.01,139000.0,,70000.0
2021-03-31,2021-05-17,10-Q,"Landos Biopharma, Inc.",LABP,CIK0001785345,USD,8200000.0,-196000.0,364000.0,-102000.0,166429000.0,1023000.0,1023000.0,1550510.0,110210000.0,109745000.0,105019000.0,112000.0,52823000.0,97786000.0,44963000.0,8572000.0,8572000.0,6156000.0,,0.01,200000000.0,39866669.0,39866669.0,399000.0,-9930000.0,,,,,,18000.0,73037000.0,,-112000.0,0.0,,43000.0,,-0.38,,,0.0,,18000.0,2646000.0,-9818000.0,-422000.0,-1575000.0,-2212000.0,,,,9031000.0,110210000.0,8819000.0,,97786000.0,0.0,90764000.0,-72048000.0,-12560000.0,-9818000.0,9900000.0,-9900000.0,-112000.0,255000.0,212000.0,,64000.0,82000.0,,81379000.0,64000.0,0.01,10000000.0,0.0,0.0,3386000.0,90506000.0,,9395000.0,258000.0,9818000.0,465000.0,7254000.0,-65547000.0,,1023000.0,9.38,0.6655,0.0046,0.0,6.68,2300000.0,0.0,349650.0,5151000.0,1653937.0,5.67,5151000.0,5.67,1.86,0.0,16.0,756000.0,101179000.0,101179000.0,,,0.0,90506000.0,558000.0,0.0,0.0,,26070455.0,262329.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-07-29,10-Q,"Landos Biopharma, Inc.",LABP,CIK0001785345,USD,10685000.0,,1590000.0,-142000.0,166805000.0,312000.0,312000.0,491650.0,118291000.0,117727000.0,113614000.0,,34247000.0,96440000.0,62193000.0,18687000.0,18687000.0,,0.0,0.01,200000000.0,39900886.0,39900886.0,399000.0,4057000.0,505000.0,0.0,0.0,172000.0,333000.0,-5000.0,,,-40000.0,0.0,,,0.12,0.12,0.12,,,,,2596000.0,4097000.0,,,,,505000.0,0.0,12679000.0,118291000.0,12530000.0,172000.0,96440000.0,,,,,4097000.0,14118000.0,3882000.0,-40000.0,,149000.0,,179000.0,215000.0,,,,0.01,10000000.0,0.0,0.0,,,,,,,564000.0,11522000.0,-61450000.0,18000000.0,,,,,,6.15,,,,7535000.0,1511937.0,6.31,7535000.0,6.31,,,,1977000.0,105612000.0,105612000.0,,,,,64000.0,0.0,0.0,34384784.0,,228112.0,33639481.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-15,10-Q,"Landos Biopharma, Inc.",LABP,CIK0001785345,USD,10114000.0,,726000.0,131000.0,167440000.0,355000.0,355000.0,1485118.0,105098000.0,104318000.0,101768000.0,,41003000.0,84777000.0,43774000.0,17893000.0,17893000.0,,0.0,0.01,200000000.0,40053157.0,12767909.0,401000.0,-12331000.0,1023000.0,0.0,0.0,390000.0,633000.0,-10000.0,,,273000.0,0.0,,,,-0.32,,,,,,3059000.0,-12604000.0,,,,,1023000.0,0.0,11180000.0,105098000.0,11095000.0,390000.0,84777000.0,,,,,-12604000.0,12403000.0,-12403000.0,273000.0,255000.0,85000.0,191000.0,,-201000.0,,,,,,,,1645000.0,,,,,,780000.0,9344000.0,-74054000.0,0.0,,,,,,7.91,,,,8865000.0,1475937.0,7.07,8865000.0,7.07,,,,1570000.0,93918000.0,93918000.0,,,,,282000.0,,0.0,,39962069.0,194020.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
